News

IMPROVE focuses on improving deep learning models to predict the efficacy of cancer treatments. The research community, including data scientists and informaticists, is asked to respond to an RFI for creating protocols to evaluate model performance by April 15, 2022, at 5:00 p.m. ET. Additionally, they are encouraged to respond to an RFP for improving model comparison by May 9, 2022.

Investigators from NCI’s Center for Cancer Research developed a software package to perform high-throughput analysis of extracellular vesicles, which are particles a cell releases that can promote cell growth and survival. NCI is now seeking research co-development partners and/or licensees for this biomarker analysis software.

The NCI CCR Liver Cancer Program is seeking a qualified computational postdoctoral candidate to fill a position in cancer genomics. Interested applicants should have a background in cancer genomics, computational biology, and/or bioinformatics.

If you’re attending the 2022 American Association for Cancer Research Annual Meeting (either in person or virtual), don’t miss these data science sessions, poster presentations, and the NCI exhibit booth, where you can hear more about our programs and activities!

Do you work on a project funded by an active NIH grant? Is this project rooted in artificial intelligence, machine learning, and/or ethics components? Apply to this Notice of Special Interest by March 31, 2022.

Over the past several years, scientists have made exciting advances in the realm of artificial intelligence (AI) and its integration into the cancer imaging field. New AI tools could make cancer imaging faster, more accurate, and more informative. But are they ready for real-world implementation?

NCI has just launched the Molecular Characterization Initiative, fostering data sharing in childhood cancer research. This program offers tumor molecular characterization to children, adolescents, and young adults who have been diagnosed with central nervous system tumors and are being treated at hospitals affiliated with an NCI-supported clinical trials group, “Children’s Oncology Group.” The DNA and RNA in participants' tumors are analyzed through this voluntary, free program. Once data is available, cancer researchers will be able to access the data via the Cancer Research Data Commons.

Are you a creative, forward-thinking individual looking to provide scientific and operational leadership to a key node in the digital biomedical ecosystem? The National Library of Medicine (a sister Institute of NCI) is seeking an innovative leader to serve as Director of its National Center for Biotechnology Information and Associate Director for Scientific Data Resources. Applications due April 23, 2022.

Looking for canine urothelial carcinoma data? RNA sequencing and clinical data from a phase I/II trial, listed in the EACR’s top 10 publications, is available for analysis through NCI’s Integrated Canine Data Commons.

Have experience with data management, high performance computing, and/or machine learning/artificial intelligence? Are you a proven IT manager and leader? Become a Staff Scientist/Facility Head to direct and manage a shared Scientific Computing and Informatics Core within the National Institute on Drug Abuse, a sister institute of the National Cancer Institute.